Its five ingredients avocado oil, jojoba oil, hemp seed oils, beeswax, and vitamin E are elegant in their simplicity
The activation of ataxia-telangiectasia mutated protein kinase (ATM) is triggered by the Mre11-Rad50-Nbs1 (MRN) complex when damage occurs, facilitating the repair of double-strand breaks
It's as nourishing as it is effective
Simple daily application works while clinical microneedling (like the 2025 Kuceki protocol) produces more dramatic results, a basic topical spray applied before bed still produces statistically significant hair growth over 6 months
It was discovered in 2012,[3] by a team of researchers at Novo Nordisk as a longer-acting alternative to liraglutide.[4] Clinical trials were started in 2015, and phase 3 was completed in 2016.[5] Researchers at the University of Leeds and Novo Nordisk reported in 2017 that it can also be used for the treatment of obesity.[6] It reduces hunger, food craving and body fat.[7] FDA approval was applied in December 2016, and in October 2017 FDA Advisory Committee voted 16-0 in favour.[8] On December 5, 2017, semaglutide was approved by the US FDA
